This topic contains a solution. Click here to go to the answer

Author Question: Internal consistency represents a measure's heterogeneity. Indicate whether the statement is true ... (Read 30 times)

WhattoUnderstand

  • Hero Member
  • *****
  • Posts: 517
Internal consistency represents a measure's heterogeneity.
 
 Indicate whether the statement is true or false

Question 2

Which of the following is not a positioning strategy that emphasizes the prospects?
 a. customer benefit c. country of origin
  b. use or application d. lifestyle



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

parker125

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

F
Internal consistency represents a measure's homogeneity.

Answer to Question 2

C
Country of origin falls under product focus.




WhattoUnderstand

  • Member
  • Posts: 517
Reply 2 on: Jun 29, 2018
Thanks for the timely response, appreciate it


rachel

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library